Hydra Biosciences
Latest round
- Series E
Last raised
- Mar 2015
Total raised
- $78M
Investors
- 10
About Hydra Biosciences
Hydra Biosciences, Inc.Founded in 2001 and headquartered in Cambridge, US, Hydra Biosciences focuses on creating therapeutics targeting various diseases.Hydra Biosciences specializes in developing and commercializing innovative therapeutics using proprietary technology. Their core offerings include drug candidates aimed at conditions in pain management and rare diseases.Hydra Biosciences generates revenue through direct sales of its therapeutics and partnerships with healthcare organizations. Their business model often involves B2B agreements with healthcare providers or distributors, potentially including volume-based pricing or milestone payments linked to the commercialization of flagship products. The company aims to expand into additional markets in North America and Europe by 2025, thereby increasing its footprint in the biopharmaceutical market while addressing unmet medical needs.
Who invested in Hydra Biosciences
10 investors across 5 rounds
See all investors in Hydra Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Hydra Biosciences
Who invested in Hydra Biosciences?
Hydra Biosciences has 10 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Hydra Biosciences raised?
Hydra Biosciences has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Hydra Biosciences last raise money?
Hydra Biosciences's most recent round on record is a Series E, in Mar 2015.
What does Hydra Biosciences do?
Hydra Biosciences is a biotechnology company.
Where is Hydra Biosciences headquartered?
Hydra Biosciences is headquartered in Cambridge, US.
Which VCs invest in companies like Hydra Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Hydra Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series E
Raising like Hydra Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.